Trial
NCT03486197
Neutron Radiation Therapy and Pembrolizumab in Treating Participants With Advanced Urothelial Carcinoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Washington
Collaborators
—
Condition
Urothelial Carcinoma
Intervention
Laboratory Biomarker Analysis
Why stopped
Closed per SRC Low Accrual Policy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-20